Stubhub on its $800 Million IPO
Cooley advised the underwriters of StubHub Holdings, a global secondary ticketing marketplace for live events, in connection with StubHub’s $800 million initial public offering (IPO). Partners David Peinsipp, Kristin VanderPas and Denny Won led the Cooley team advising the underwriters.
LB Pharmaceuticals on its $285 Million IPO
Cooley advised LB Pharmaceuticals, a clinical-stage biopharmaceutical company developing novel therapies for the treatment of neuropsychiatric diseases including schizophrenia, on its $285 million upsized initial public offering (IPO). Lawyers Brandon Fenn, Divakar Gupta, Marc Recht, Minkyu Park, Denny Xu, Danbi Kim, Ariane Andrade, Nathaniel Hearn and Karun Ahuja led the Cooley team advising […]
Heartflow on its $364.2 Million Upsized IPO
Cooley advised the underwriters of Heartflow, a leader in artificial intelligence technology for coronary artery disease, in connection with Heartflow’s $364.2 million upsized initial public offering (IPO). Partners David Peinsipp, Kristin VanderPas, Charlie Kim and Denny Won led the Cooley team advising the underwriters.
Ambiq Micro on its $110.4 Million IPO
Cooley advised Ambiq Micro, a technology leader in ultra-low-power semiconductor solutions for edge artificial intelligence, on its $110.4 million initial public offering (IPO). Lawyers Christina Roupas, Courtney Tygesson, Michael Platt, Kelly Bartling and Grady Chang led the Cooley team advising Ambiq.
Caris Life Sciences on its $494 Million IPO
Cooley advised the underwriters of Caris Life Sciences, a patient-centric, next-generation artificial intelligence techbio company and precision medicine pioneer, in connection with Caris’ $494 million initial public offering (IPO).
AIRO Group on its $69 Million IPO
Cooley advised AIRO Group Holdings, a company specializing in advanced aerospace and defense technologies, on its $69 million initial public offering (IPO). Lawyers Christina Roupas, Yvan-Claude Pierre, Courtney Tygesson and Grady Chang led the Cooley team advising AIRO.
Beta Bionics on its $234.6 Million IPO
Cooley advised Beta Bionics, a pioneering leader in the development of advanced diabetes management solutions, on its upsized $234.6 million initial public offering (IPO) and concurrent $17 million private placement. Partners Carlos Ramirez, Mark Weeks and Charlie Kim led the Cooley team advising Beta Bionics.
Artiva Biotherapeutics on its $167 Million IPO
Cooley advised Artiva Biotherapeutics, a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients with devastating autoimmune diseases and cancers, on its upsized $167 million initial public offering. Partners Carlos Ramirez and Charlie Kim led the Cooley team advising Artiva.
Tempus AI on its $410.7 Million IPO
Cooley advised Tempus AI, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, on its $410.7 million initial public offering. Chicago partners Christina Roupas and Courtney Tygesson led the Cooley team, which also included Richard Segal and Eric Jensen.
Life360 on its $178.5 Million IPO
Cooley advised Life360, a family connection and safety company, on its $178.5 million initial public offering. Lawyers Thomas Hopkins, David Peinsipp, Siana Lowrey, Natalie Karam and Alexander Gefter led the Cooley team advising Life360.